RAC 5.59% $1.70 race oncology ltd

Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-66

  1. 709 Posts.
    lightbulb Created with Sketch. 277
    Hi JD
    There are many companies following the  virotherapy and CPI route. Have a look at Targovax CPI resistant melanoma results from last year (from memory 35% response rate treating failed cpi treated cases)
    If you want more science have a look at this paper
    https://www.cell.com/molecular-therapy-family/oncolytics/fulltext/S2372-7705(21)00024-3
    specifically look at the response rate figure from the same model (B-16) that Race has used and compare the results. You will see there is complete inhibition of tumor growth and the activation of a systemic abscopal  effect.
    There are many other examples.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.70
Change
0.090(5.59%)
Mkt cap ! $289.5M
Open High Low Value Volume
$1.60 $1.76 $1.59 $142.7K 84.97K

Buyers (Bids)

No. Vol. Price($)
2 17175 $1.70
 

Sellers (Offers)

Price($) Vol. No.
$1.77 6060 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.